On Tuesday, May 21, at 1:00 p.m. ET, join the FDA’s Division of Drug Information for a webinar on the emerging paradigm shift in drug manufacturing through 3D printing.
Specifically, the webinar will cover:
- The fundamental principles of 3D printing as they relate to the design and manufacture of pharmaceutical drug products
- The motivation driving the paradigm shift of on-demand manufacturing of personalized medicine
- How various types of 3D printing platforms operate, their capability with respect to complex and precision drug design, manufacturing design, and flexibility, as well as how they compare with current practice
- Upcoming regulatory challenges of this 21st century digitalized manufacturing and its impact on health care structure
This free session will be presented by Akm Khairuzzamn, PhD, senior chemistry reviewer in the FDA’s Office of New Drug Products, Office of Pharmaceutical Quality.
This activity is designated for 1.00 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.
To register, please visit the FDA website.